HAPILA finds high demand for its enhanced API development and supply capabilities at CPHI Frankfurt

HAPILA GmbH News Releases

Find the latest News from HAPILA GmbH

Page 2 of 3
HAPILA finds high demand for its enhanced API development and supply capabilities at CPHI Frankfurt
HAPILA finds high demand for its enhanced API development and supply capabilities at CPHI Frankfurt Learn More >
HAPILA commences cGMP pilot scale manufacture of anti-TB API BTZ-043
HAPILA commences cGMP pilot scale manufacture of anti-TB API BTZ-043 Learn More >
HAPILA brings API manufacturing solutions to Chemspec Europe 2022
HAPILA brings API manufacturing solutions to Chemspec Europe 2022 Learn More >
CEP Revision extends HAPILA Estriol API retest period to 60 months
CEP Revision extends HAPILA Estriol API retest period to 60 months Learn More >
HAPILA extends co-operation with Transo-Pharm  to meet Estriol demand
HAPILA extends co-operation with Transo-Pharm to meet Estriol demand Learn More >
Authorities confirm cGMP status for HAPILA’s Estriol estrogen API manufacturing
Authorities confirm cGMP status for HAPILA’s Estriol estrogen API manufacturing Learn More >
HAPILA starts optimized pilot scale production of BTZ-043 anti TB agent
HAPILA starts optimized pilot scale production of BTZ-043 anti TB agent Learn More >
HAPILA reaching completion of design for new GMP production plant for APIs
HAPILA reaching completion of design for new GMP production plant for APIs Learn More >
HAPILA extends analytical gas chromatography capabilities
HAPILA extends analytical gas chromatography capabilities Learn More >
HAPILA extends production capacity by installation of a pilot plant for BTZ043 anti-TB agent
HAPILA extends production capacity by installation of a pilot plant for BTZ043 anti-TB agent Learn More >
Authorities extend CEP certification for HAPILA’s Estriol estrogen API
Authorities extend CEP certification for HAPILA’s Estriol estrogen API Learn More >
HAPILA becomes a teenager
HAPILA becomes a teenager Learn More >
Page 2 of 3